AFC-HD AMS Life Science Co., Ltd.
TSE:2927.T
835 (JPY) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 25,579.009 | 22,997.127 | 22,368.076 | 15,819.281 | 16,252.889 | 15,795.643 | 15,141.754 | 14,631.256 | 14,415.229 | 13,727.896 | 14,366.178 | 14,794.674 | 14,653.831 | 14,448.963 | 12,813.393 | 10,221.995 |
Cost of Revenue
| 16,256.131 | 14,418.164 | 15,503.067 | 11,264.68 | 11,732.032 | 11,203.039 | 10,533.969 | 10,241.369 | 10,154.373 | 9,615.858 | 9,929.886 | 10,052.382 | 9,266.426 | 9,245.919 | 7,897.28 | 6,107.288 |
Gross Profit
| 9,322.878 | 8,578.963 | 6,865.009 | 4,554.601 | 4,520.857 | 4,592.604 | 4,607.785 | 4,389.887 | 4,260.856 | 4,112.038 | 4,436.292 | 4,742.292 | 5,387.405 | 5,203.044 | 4,916.113 | 4,114.707 |
Gross Profit Ratio
| 0.364 | 0.373 | 0.307 | 0.288 | 0.278 | 0.291 | 0.304 | 0.3 | 0.296 | 0.3 | 0.309 | 0.321 | 0.368 | 0.36 | 0.384 | 0.403 |
Reseach & Development Expenses
| 145.058 | 153.029 | 163.7 | 166.359 | 156.62 | 139.187 | 116.114 | 110.139 | 108 | 105 | 82 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 6,633.457 | 6,525.795 | 3,913.821 | 2,902.277 | 2,876.945 | 2,842.913 | 2,882.403 | 2,900.89 | 2,846 | 2,999 | 2,982 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 748 | 736 | 504 | 438 | 505 | 586 | 539 | 487 | 428 | 517 | 500 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 7,381.457 | 7,261.795 | 4,417.821 | 3,340.277 | 3,381.945 | 3,428.913 | 3,421.403 | 3,387.89 | 3,274 | 3,516 | 3,482 | 0 | 0 | 0 | 0 | 0 |
Other Expenses
| 23.228 | 7,567.815 | 4,619.768 | 3,460.922 | 3,539.585 | 12.638 | 36.464 | 0.192 | 35.833 | 53.911 | 42.75 | 105.057 | 54.502 | 92.67 | 56.426 | 103.922 |
Operating Expenses
| 7,686.592 | 7,567.815 | 4,619.768 | 3,460.922 | 3,539.585 | 3,569.12 | 3,538.537 | 3,499.049 | 3,309.66 | 3,547.511 | 3,534.139 | 4,031.102 | 4,362.733 | 4,435.318 | 4,178.423 | 3,265.17 |
Operating Income
| 1,636.285 | 1,385.792 | 2,245.239 | 1,093.679 | 981.271 | 1,023.483 | 1,069.247 | 890.838 | 951.194 | 564.527 | 902.152 | 711.189 | 1,024.67 | 767.724 | 737.69 | 849.536 |
Operating Income Ratio
| 0.064 | 0.06 | 0.1 | 0.069 | 0.06 | 0.065 | 0.071 | 0.061 | 0.066 | 0.041 | 0.063 | 0.048 | 0.07 | 0.053 | 0.058 | 0.083 |
Total Other Income Expenses Net
| -90.316 | -150.353 | -87.432 | -89.336 | 109.753 | -37.83 | -431.953 | -135.77 | 4.573 | -70.275 | 74.615 | 255.628 | -95.764 | -83.468 | -313.447 | -43.753 |
Income Before Tax
| 1,545.969 | 1,235.439 | 2,157.807 | 1,004.343 | 1,091.024 | 985.653 | 637.295 | 755.068 | 955.769 | 494.252 | 976.768 | 966.818 | 928.908 | 684.258 | 424.243 | 805.784 |
Income Before Tax Ratio
| 0.06 | 0.054 | 0.096 | 0.063 | 0.067 | 0.062 | 0.042 | 0.052 | 0.066 | 0.036 | 0.068 | 0.065 | 0.063 | 0.047 | 0.033 | 0.079 |
Income Tax Expense
| 439.356 | 497.922 | 662.358 | 327.659 | 307.732 | 248.972 | 171.402 | 269.185 | 355.742 | 211.273 | 404.376 | 397.773 | 438.748 | 489.216 | 294.526 | 450.96 |
Net Income
| 1,102.563 | 735.353 | 1,495.554 | 676.683 | 783.292 | 736.68 | 465.893 | 489.6 | 605.503 | 282.979 | 572.392 | 569.044 | 490.159 | 195.042 | 129.717 | 354.824 |
Net Income Ratio
| 0.043 | 0.032 | 0.067 | 0.043 | 0.048 | 0.047 | 0.031 | 0.033 | 0.042 | 0.021 | 0.04 | 0.038 | 0.033 | 0.013 | 0.01 | 0.035 |
EPS
| 78.51 | 52.33 | 107.12 | 48.12 | 55.7 | 58.28 | 38.48 | 40.47 | 50.64 | 23.82 | 48.14 | 47.74 | 41.13 | 16.35 | 10.82 | 29.55 |
EPS Diluted
| 78.46 | 52.08 | 106.3 | 48.12 | 55.7 | 58.28 | 38.48 | 40.34 | 50 | 23.48 | 48.14 | 47.74 | 41.12 | 16.34 | 10.8 | 27.53 |
EBITDA
| 2,659.797 | 2,392.412 | 2,863.278 | 1,638.385 | 1,502.475 | 1,462.358 | 1,489.518 | 1,287.79 | 1,426.887 | 1,127.521 | 1,543.094 | 1,546.718 | 1,443.692 | 1,292.521 | 1,185.12 | 1,232.414 |
EBITDA Ratio
| 0.104 | 0.104 | 0.128 | 0.104 | 0.092 | 0.093 | 0.098 | 0.088 | 0.099 | 0.082 | 0.107 | 0.105 | 0.099 | 0.089 | 0.092 | 0.121 |